BJ
Bhavik Jain
About Bhavik Jain
Data last updated:
Bhavik Jain is a Director at Fitwel Pharmaceuticals Private Limited (since 2014), Director at Gelmek Healthcare Private Limited (since 2018) and Designated Partner at Eurus Lifesciences Llp (since 2017), and holds 2 more current directorships. The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹36.38 Cr; the largest is Fitwel Pharmaceuticals Private Limited at ₹25.09 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Jul 2014 | 2014 | ₹25.09 Cr (FY 2025) | Active | |
| Director | 11 Sep 2018 | 2018 | ₹9.92 Cr (FY 2025) | Active | |
| Designated Partner | 08 Dec 2017 | 2017 | ₹1.37 Cr (FY 2021) | Active | |
| Director | 25 Apr 2025 | 2025 | Active | ||
| Director | 04 Jul 2024 | 2024 | Active |
Board colleagues of Bhavik Jain
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhavik Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhavik Jain
Bhavik Jain currently holds 5 directorships: Fitwel Pharmaceuticals Private Limited (Director, since 15 Jul 2014, revenue ₹25.09 Cr (FY 2025)); Gelmek Healthcare Private Limited (Director, since 11 Sep 2018, revenue ₹9.92 Cr (FY 2025)); Eurus Lifesciences Llp (Designated Partner, since 08 Dec 2017, revenue ₹1.37 Cr (FY 2021)); Favion Healthcare Private Limited (Director, since 25 Apr 2025); Euraphor Lifesciences Private Limited (Director, since 04 Jul 2024).
Bhavik Jain was first appointed on 15 Jul 2014 as Director at Fitwel Pharmaceuticals Private Limited. The most recent appointment on record is 25 Apr 2025 at Favion Healthcare Private Limited.
The 3 current companies of Bhavik Jain that report revenue have a combined latest revenue of ₹36.38 Cr: Fitwel Pharmaceuticals Private Limited ₹25.09 Cr (FY 2025); Gelmek Healthcare Private Limited ₹9.92 Cr (FY 2025); Eurus Lifesciences Llp ₹1.37 Cr (FY 2021).
The current boards of Bhavik Jain's companies include Bhupendra Kumar Jain (Fitwel Pharmaceuticals Private Limited), Chandra Kant Jain (Fitwel Pharmaceuticals Private Limited), Krutika Jain (Fitwel Pharmaceuticals Private Limited), Kshitij Jain (Fitwel Pharmaceuticals Private Limited), Arupee Sharan Gupta (Gelmek Healthcare Private Limited), Karan Rijhwani (Gelmek Healthcare Private Limited), among others.